Introduction
A common mutation of the methylenetetrahydrofolate reductase (MTHFR) gene 677C-T, which results in mild enzyme deficiency, has drawn attention because its allelic prevalence is high in many populations (about 35-40% among Caucasian and Asian populations, and about 15À20% for individuals who are homozygous TT for the mutation). 1, 2 Studies in different populations have found a protective effect of the MTHFR T allele against adult and childhood acute lymphocytic leukemia [3] [4] [5] [6] [7] [8] [9] and malignant lymphoma, 10, 11 and this protective effect appeared to be closely associated with folate status. 3, 10, 12 One study also found that MTHFR polymorphisms are independent prognostic markers influencing progression-free survival in patients with early-stage B-chronic lymphocytic leukemia. 13 On the other hand, MTHFR gene variants do not have a major influence on the susceptibility to acute lymphocytic leukemia in Mediterranean 14 or German populations. 15 Studies have indicated that MTHFR polymorphisms do not significantly contribute to an inherited genetic susceptibility to non-Hodgkin lymphoma 16 or chronic lymphocytic leukemia. 17 These findings may reflect differences in folate status between study populations, or folate metabolism has different impacts on different subtypes of hematological malignancies. MTHFR TT genotype was found associated with increased risk and mortality of prostate, kidney and bladder cancers, particularly among those with lower folate intake, those with higher alcohol intake and older-aged men. 18 These studies suggested that MTHFR could impact tumorigenesis in a tissue-specific manner, and genetic predisposition is closely related to environmental factors such as folate status.
Folate-dependent one-carbon metabolism is essential for DNA synthesis and methylation, both of which could potentially affect cancer susceptibility. Folate or other methyl donor deficiency in animals may induce an imbalance in the deoxynucleotide precursors for DNA replication/repair and negatively affect the fidelity of DNA synthesis, and predispose to uracil misincorporation and DNA repair-related DNA strand breaks. 19 Dietary folate deficiency produced progressive DNA strand breaks within exons 5-8 of the p53 gene in rat colon, 20 and dietary folate supplementation significantly protected against small intestinal and colorectal tumorigenesis in mice when folate is provided before occurrence of tumor. 21 However, the mechanism by which the T allele and folate status modify cancer risk remained to be determined. Mutation of cytosine to thymidine at nucleotide 677 (677C-T) of the MTHFR gene leads to an alanine to valine substitution in this position in exon 4, 22 resulting in a thermolabile enzyme with reduced specific activity (approximately 35% of control values in homozygous mutant individuals). 22, 23 Concentrations of 5-methyltetrahydrofolate (methylTHF) in transformed lymphoblasts of the TT genotype were approximately half in the CC genotype under adequate nutrient conditions. 24 Restriction of folate and riboflavin resulted in increased homocysteine accumulation and decreased methionine production in the TT genotype, emphasizing gene-nutrient interactions. 24 Human HCT116 colon and MDA-MB-435 breast cancer cells stably transfected with mutant 677T human MTHFR cDNA had decreased MTHFR activity, had MTHFR thermolability, changed intracellular folate distribution, accelerated cellular growth rate and increased thymidylate synthase activity. 25 Xenografts expressing the mutant 677T MTHFR grew faster in nude mice. 25 Antisense against MTHFR showed significant inhibitory effects in growth of human colon, lung, breast, prostate and neuroblastoma tumor cells in vitro and it was suggested that inhibition of MTHFR may be a novel anticancer approach. 26 Global genomic hypomethylation is associated with malignant lymphoproliferative diseases. 27 Aberrant DNA methylation of promoter-associated CpG islands is very common in hematological malignancies 28 including adult acute lymphoblastic leukemia 29, 30 and cutaneous T-cell lymphoma, 31 the profile of CpG island hypermethylation in hematologic malignancies could be an epigenetic signature unique for each subtype of leukemia or lymphoma. 32 On the other hand, promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis 33 and non-Hodgkin's lymphoma. 27 In the present study, we investigated the biochemical impacts of MTHFR 677C-T on cellular S-adenosyl methionine (adoMet) synthesis, global DNA methylation, de novo purine synthesis and thymidine synthesis, all of which may be potential regulatory pathways involved in tumorigenesis. Metabolic fluxes of homocysteine remethylation and de novo purine synthesis were compared between Epstein-Barr virus-transformed lymphoblasts expressing MTHFR 677C and MTHFR 677T using stable isotopic tracers and gas chromatography/mass spectrometry (GCMS). The systemic metabolic fluxes in folate pathways have been studied in mice as well as in humans with reduced MTHFR activity. In mice with reduced MTHFR activity, a reduction in homocysteine remethylation was only found when these mice had low folate status, indicating that the phenotypic expression of MTHFR is closely related to folate status (Chiang unpublished data). However, our previous attempt to trace the pathway of de novo purine biosynthesis by labeled serine was not successful in mice owing to the dilution of endogenous serine in vivo. Serine enrichment was diluted about 10-fold, which made it difficult to accurately quantify the relative flux in de novo purine synthesis in these mice. In humans, young women with TT genotype had elevated homocysteine synthesis, but total remethylation is unchanged by the MTHFR 677C-T polymorphism. 34 In spite of the presence of formyl-tetrahydrofolate in erythrocytes in TT subjects, purine enrichment appeared unchanged by MTHFR or folate depletion. 35 The in vivo impacts of MTHFR on homocysteine homeostasis and nucleotide synthesis are fairly complex and it is possible that the above in vivo studies missed smaller but real differences in flux changes. An in vitro model would be feasible in studying de novo purine synthesis by the precursor serine. The in vitro cell model also enables investigation of cell-type specific impacts of MTHFR under controlled nutritional status. The present study utilized transformed lymphoblasts to investigate the influences of genetic variations in MTHFR and its interactions with folate status on de novo purine and thymidine biosynthesis and transmethylation pathway. Data from the present study may shed light on the potential regulatory mechanism by which MTHFR modulates the risk for hematopoietic malignancies.
Materials and methods

Chemicals and cell culture
All chemicals were purchased from Sigma Chemical Company (St Louis, MO, USA) unless otherwise specified. The human Epstein-Barr virus-transformed lymphoblasts (Coriell Institute, Camden, NJ, USA) expressing common polymorphic alleles, 677C and 677T, of the MTHFR gene were grown in RPMI 1640 medium with 15% fetal bovine serum (FBS) (TerraCell International, Ontario, Canada), penicillin (100 000units/l), streptomycin (100 mg/l), amphotericin (0.25 mg/ml) and 5% CO 2 in an incubator at 371C. The media were replaced every 72 h and cell numbers were counted using trypan blue exclusion. To study the impacts of physiologically low folate status, a mild folate restriction was used in the experiments. After 6 days of such folate restriction, cell growth drastically declined and a longer duration of restriction made labeling experiments rather difficult because of low incorporation of tracer into cellular protein and DNA. In each experiment, cells were cultured in either mildly low folate (10 nM folinate) or abundant folic acid (2.2 mM) RPMI 1640 (Gibco Invitrogen, Carlsbad, CA, USA) media for 6 days. In stable isotope labeling experiments, protein turnover was assessed using leucine labeling to take into account the potential influence of growth variations among these cell lines. The impacts of folate restriction were examined separately in each cell line and compared to the same cell line under folate-replete conditions. The percentage changes in metabolic fluxes in methionine, purine and pyrimidine syntheses, and in the concentrations of S-adenosylmethionine (adoMet), S-adenosylhomocysteine (adoHcy) and 5-methyl deoxycytidine (dMC) were calculated for each cell line.
Determination of intracellular S-adenosylmethionine and S-adenosylhomocysteine concentrations
After the incubation period, cells were harvested, washed and pelleted by centrifugation. Cell pellets were hand homogenized on ice in 0.4 M ice-cold perchloric acid. Homogenates were centrifuged and supernatants were collected and stored at À801C until analyzed. Intracellular adoMet and adoHcy were determined by a procedure described previously. 36 Briefly, the supernatant of each sample was filtered through 0.45 mM and then loaded onto a C18 column (250 Â 4.6 mm), fitted with matched guard column operated by a Hitachi L-7100 intelligent pump connected to an L-7400 UV detector. Absorption of eluted compounds was monitored using ex ¼ 254 nm. Values were normalized to cellular protein content that was determined using the bicinchoninic acid assay (BCA) method (Pierce, Rockford, IL, USA). All analyses were performed in triplicate and repeated using three different cell lysates.
Determination of global DNA methylation
Cells were harvested after incubation; then DNA was isolated using a standard phenol/chloroform/isoamyl alcohol procedure. 37 The degree of global DNA methylation was determined by measuring the dMC content in the DNA as described by Cooney 38 The molar %dMC, that is 100 Â 5dMC/(dC þ 5dMC), was calculated for DNA.
Stable isotope tracer studies
Kinetic experiments were conducted using specific stable isotopic tracers (Cambridge Isotope Laboratories, Woburn, MA, USA) to investigate the impacts of MTHFR 677T on (1) purine synthesis, (2) thymidylate synthesis and (3) homocysteine metabolic pathways at different folate levels.
Overall homocysteine remethylation flux was assessed by 13 C 5 -methionine. As 13 C 5 -methionine enters the methionine cycle, it loses one methyl group and generates 13 C 4 -homocysteine after transmethylation. 13 C 4 -homocysteine then remethylated to methionine via the folate-dependent or independent remethylation pathway and generating 13 C 4 -methionine. The ratio between the absolute enrichments in existing M þ 4 and M þ 5 methionine species reflected the degree of overall remethylation of homocysteine. Folatedependent homocysteine was assessed by labeling experiments using 13 C-serine as the tracer. This reaction was catalyzed by methionine synthase and 13 C-methionine was produced. The b carbon of serine serves as the major one-carbon source in the folate cycle that can be transferred to methylTHF. It is subsequently used for methionine synthesis via folate-dependent homocysteine remethylation. The folate-dependent homocysteine remethylation was calculated as the ratio between the absolute enrichments of 13 C-methionine and that of 13 C-serine. Cells were seeded in T-25 flasks at the density of 250 000 per millimeter in medium with abundant folate (RPMI 1640 with 2.2 mM folate) or mildly low folate (RPMI 1640 with 10 nM folinate) for 144 h. After 72 h of incubation, medium was supplemented with either
leucine (381.1 mM) for and additional 72 h. After the labeling period, medium was removed and cells washed twice with icecold PBS. Isotopic enrichment was determined in positive ionization mode for nucleotides and negative ionization mode for amino acids by GC/MS. Selected ion monitoring was conducted at a mass-to-charge ratio m/z 255-257 for thymine, m/z 280-283 for adenine and m/z 368-371 for guanine; and a mass-to-charge ratio m/z 519-523 for serine, m/z 349-353 for leucine, m/z 367-372 for methionine as described previously. 39 
Statistical analyses
The effects of MTHFR genotype, folate status and the effect of their interactions on metabolic fluxes in methionine and nucleotide syntheses, intracellular contents of the adoMet, adoHcy and dMC were examined by analysis of variance (ANOVA).
Results
Effect of mild folate restriction on protein turnover, transmethylation, DNA synthesis and methylation in transformed lymphoblasts Doubling time increased significantly in all lymphoblasts (both CC and TT genotypes) under the mild folate restriction used in the present study. Amino acid stable isotopic tracer enrichments are shown in Table 1 . Mild folate restriction did not alter total protein turnover, as assessed by leucine labeling. The greater 13 C-serine enrichment under folate restriction indicated that relatively more exogenous serine was utilized in cytoplasm for protein synthesis under this condition (Table 1a) . Mild folate restriction resulted in drastically reduced fluxes in methionine (Table 1a) and thymidylate (Table 1b) synthesis but unaltered that in purine precursor (Table 1b) . Although mild folate restriction significantly decreased the adoMet to adoHcy ratio, the percentage of dMC in genomic DNA did not change under this condition (Table 1c) .
Effect of the MTHFR 677T polymorphism on cell growth, protein turnover and intracellular folate pools during mild folate restriction.
Leucine enrichments did not differ between the CC genotype (abbreviated as CC below) and the TT genotype (abbreviated as TT below) in either folate repletion or mild restriction, indicating that neither MTHFR genotype nor the mild folate restriction affects protein turnover in these cells. Thymidylate enrichments from 13 C-serine precursor did not differ between the two genotypes in folate repletion (Table 2a) . ANOVA indicated significant genotype and folate effects but no effect of interaction between the two on the thymidylate enrichments. Mild folate restriction reduced thymidylate enrichment from labeled serine by about 17% in both CC and TT (Table 2b) , presumably due to reduction in the intracellular pool of 5,10-methyleneTHF. These results suggest that the methylene tetrahydrofolate (methyleneTHF) pools were similar in CC and TT in folate repletion, and folate restriction impacts the MTHF pool to the same extent in both genotypes. In contrast, in folate abundance, relative enrichment in the purine þ 1 species was greater in TT by 25-40% compared with CC, suggesting a possible relative enrichment of the 10-formylTHF pool in TT under this condition (Table 2a ). The greater labeling in purines and similar enrichments in thymidine suggests that TT utilizes better exogenous serine for purine synthesis without altering the incorporation of one-carbon units into thymidylate in these cells when folate is abundant. Mild folate restriction appeared to have stronger impacts on purine synthesis in TT than CC. ANOVA indicated a significant genotypic effect but not a folate effect on the enrichments in adenine/guanine from the 13 C-serine precursor. Mean enrichment in adenine (dA) and guanine (dG) was higher when folate was abundant, suggesting that relative proportion of 10-formylTHF could be increased in TT under this condition. MTHFR genotype appeared to have stronger effects than folate status on purine synthesis, whereas folate status had stronger effects on thymidylate and homocysteine remethylation (Table 3) .
A modest effect of interaction (P ¼ 0.044) between the MTHFR genotype and folate status on adenine enrichment was observed (Table 2b ), suggesting that the potential advantage of purine synthesis in TT observed in folate repletion may be compromised even under mild folate restriction.
Effect of the MTHFR 677T polymorphism and folate status on methionine regeneration
The effects of MTHFR genotype, folate status and their interactions on homocysteine remethylation/methionine regeneration were examined by ANOVA. Mild folate restriction significantly decreased the relative metabolic flux of homocysteine through the remethylation pathway (Table 3 ). Mild folate restriction had a strong effect (Po0.0001) on overall homocysteine remethylation. A modest MTHFR genotypic effect (P ¼ 0.06) and an effect of interaction between the MTHFR genotype and folate status (P ¼ 0.049) were observed on the methionine enrichments in the newly synthesized protein.
Homocysteine remethylation specifically via the methylTHF pool was further investigated using the 13 C-serine tracer. When folate was adequate, no difference was found between CC and TT in the relative enrichment of the methionine M þ 1 coming from 13 C-serine tracer. When cellular folate was restricted, the average remethylation decreased in all cell lines (Table 4) . MTHFR genotype did not affect folate-dependent homocysteine remethylation when cellular folate was adequate (P ¼ 0.593). When folate was restricted, the folate-dependent remethylation pathway in TT genotype was significantly reduced compared to CC (CC vs. TT ¼ 0.04870.007 vs. 0.00870.001, P ¼ 0.043) (Table 4) , presumably because methylated folate levels are limited in TT under this condition. These data suggest the phenotypic expression of MTHFR on methionine regeneration is closely related to folate status.
Effect of the MTHFR 677T on intracellular content of the adoMet, adoHcy and global DNA methylation during mild folate restriction
The average concentrations of intracellular adoMet and methylated cytidine (dMC) were higher in TT cell lines when All data are presented as means7s.d. (n ¼ 4) and all data were compared between folate repletion and depletion. Abbreviations: dA, adenosine; dG, guanine; dT, thymine; adoHcy, S-adenosylhomocysteine; adoMet, S-adenosyl methionine; dMC, % methylcytosine in DNA. 1 For folate dependent remethylation, data were calculated as the M+1 methionine specie divided by the serine M+1 specie from the 13 C serine precursor. 2 Overall homocysteine remethylation was calculated as the M+4 methionine specie divided by the serine M+5 specie from the 13 C 5 methionine precursor. (Table 5 ). The average reduction in adoMet in TT (À27.876.7%) was about three times that in CC (À8.977.7%) during folate restriction, and the effect of genotype (P ¼ 0.002), folate (P ¼ 0.024) as well as of the interaction between the two (P ¼ 0.012) on adoMet concentrations was significant, suggesting that adoMet homeostasis in TT was more sensitive to folate restriction. Finally, the reduction in adoMet owing to mild folate restriction did not alter the content of dMC in the DNA in any of the cell lines investigated.
Discussion
Antisense inhibition of MTHFR was reported to decrease tumor cell survival in human cancers in colon, lung, breast, prostate and neuroblastoma in vitro and in colon tumor growth in vivo.
40
The compromised MTHFR activity was also associated with increased amounts of an apoptosis marker, hence MTHFR inhibition was proposed as a novel anticancer approach. MTHFR plays a crucial role in folate coenzyme cycling and the partitioning of one-carbon units. Polymorphic variants of MTHFR were associated with some protection from the development of leukemias. Carriers of C677T were found to have reduced risk for leukemias with MLL translocations, and A1298C homozygotes and C677T homozygotes were associated with reduced risk for hyperdiploid leukemias. 7 These studies emphasized that partitioning between folate coenzymes has significant influence on development of subgroups of leukemias. It has been hypothesized that polymorphic variants of MTHFR lead to increase in thymidine pool size and improved quality of DNA synthesis that confer some measure of protection against the development of leukemias. 7 In the present study, we investigated the impacts of MTHFR 677C-T on the partitioning of one-carbon units between methionine regeneration and de novo purine and thymidylate syntheses under different folate conditions. MTHFR deficient fibroblasts were reported to synthesize normal or high serine concentrations from formate, 41 suggesting that MTHFR could alter the availability of reduced folate coenzymes. Excessive L-methionine inhibited folate-dependent thymidylate synthesis in Raji cells 42 because more one-carbon units were used in the synthesis of serine needed for homocysteine detoxification. These studies suggested that cellular methyleneTHF concentration regulates the flux of this metabolite into pathways that biosynthesize nucleotides and regenerate methionine, and the thymidine synthase activity is highly dependent on methyleneTHF availability. 41, 43 It was suggested that MTHFR and thymidine synthase directly compete for a common cellular pool of methyleneTHF, and folate coenzymes are preferentially directed toward adoMet-dependent methylation reactions at low cellular folate concentrations. 43, 44 MTHFR activity was found less sensitive to changes in methyleneTHF availability, whereas thymidine synthase activity was highly dependent on them, 43, 44 suggesting that adoMet has a higher metabolic priority when folate was limited. We observed different responses in this regard in our lymphoblast model. Both thymidylate and methionine syntheses were drastically reduced, whereas purine precursor synthesis appeared to be unaltered by mild folate restriction in these cells. In Table 2 Effect of the MTHFR 677T polymorphism and folate status on protein turnover, intracellular 10-formylTHF 1 The 10-formyl THF pool was assessed by the enrichments in the M+1 specie of purines from The methyleneTHF pool was assessed by the enrichments in the M+1 specie of thymidylate from 13 C-labeled serine precursor. 3 Cells were cultured in 2.2 mM folate for 144 h. 4 Cells were cultured in 10 nM folinate for 144 h. Percentage change was calculated for each individual cell line and then averaged. 6 Interactions between folate status and MTHFR genotype.
Effects of MTHFR polymorphisms and folate status on one-carbon metabolic fluxes E-P Chiang et al other words, purine synthesis appeared to be resistant to mild folate restriction, whereas thymidylate and methionine syntheses were highly dependent on methyleneTHF availability. We conclude that methyleneTHF and methylTHF pools are more sensitive to mild folate restriction than the formylTHF pool, and purine synthesis has higher metabolic priority than adoMet in these transformed lymphoblasts, possibly because the lymphoblast is not the main site for adoMet-dependent methylation. Furthermore, TT promotes the biosynthetic incorporation of onecarbon units into nucleotides (especially into purine precursors), without altering the biosynthetic incorporation of one-carbon units into methionine (from serine) in these cells when folate supply is abundant. The approximate 25% greater labeling of purine precursors in TT suggests that TT could better utilize folate coenzymes for purine synthesis when folate is optimal. These results support the idea that increased cellular level of methyleneTHF would permit the use of more one-carbon units for nucleotide biosynthesis. 43 On the other hand, when folate was mildly restricted, reduced MTHFR could no longer shift the partitioning toward formylTHF, suggesting the advantage of onecarbon partitioning into purine synthesis only exists when folate supply is abundant. Metabolic flux in thymidylate synthesis was decreased by folate restriction to the same extent in both TT and CC, indicating that thymidylate synthesis is highly dependent on methyleneTHF availability in these lymphoblasts regardless of MTHFR genotype. We found that folate restriction caused greater reduction in adoMet-and folate-dependent methionine synthesis in TT. The percentage reduction in adoMet during folate restriction in TT was about three times than in CC, uggesting a much lower synthesis and/or higher utilization of adoMet in TT under folate restriction.
Human HCT116 colon and MDA-MB-435 breast cancer cells that expressed mutant 677T human MTHFR cDNA had accelerated cellular growth rate and increased thymidine synthase activity, 25 whereas we found no difference in thymidylate synthesis between TT and CC in the transformed lymphoblasts, suggesting tissue-specific impacts of MTHFR 677T on nucleotide synthesis. These findings may partially explain the variability of association between MTHFR 677T and occurrence of various types of cancer in different epidemiological studies. The variation in folate conditions among different populations could also account for the different impacts of MTHFR 677T on susceptibility to different types of malignancies.
Kinetic studies in human subjects indicated marginally higher mean thymidylate synthesis in monocytes of TT carriers, whereas purine enrichment 35 or total homocysteine remethylation flux 34 was not affected by genotype or folate depletion. The deoxyadenosine to deoxyguanosine enrichment ratio was significantly higher in TT subjects, suggesting that the rate of adenine synthesis is greater than that of guanine, 35 but the physiological significance of this observation remained to be determined. By using these transformed lymphoblasts, we demonstrated significantly increased purine synthesis and marginally increased thymidylate synthesis in TT. The advantage in de novo purine synthesis found in TT may account in part for the protective effect of reduced MTHFR in several hematological malignancies. To our knowledge, this is the first study demonstrating that MTHFR 677T mutation is responsible for relatively better utilization of one-carbon units in purine synthesis when folate supply is optimal, and this advantage in purine synthesis disappeared in folate restriction. Our present study also demonstrated that lymphoblast expressing TT had reduced folate-dependent methionine synthesis when folate was restricted. As many cancer cell lines are methionine dependent and they decrease proliferation when methionine supply is limited, 45 reduced MTHFR activity could indirectly affect tumor growth by altering methionine supply. Reduced MTHFR activity might alter cancer risk via its regulation of adoMet homeostasis. Methylation of genomic DNA is dependent on an adequate With 10 nM of folate treatment for 144 h. 4 Percentage decrease in low folate compared to high folate status was calculated for individual cell-line and then averaged. *P ¼ 0.08 when TT was compare to CC. Cells were cultured in 10 nM folinate for 144 h. 4 Percentage change in response to folate restriction compared to folate replete status was calculated for each individual cell line for each genotype and then averaged. 5 Interactions between folate status and MTHFR genotype.
Effects of MTHFR polymorphisms and folate status on one-carbon metabolic fluxes E-P Chiang et al folate coenzymes and cellular adoMet supply. Aberrant methylation plays a significant role in tumorigenesis. It was reported that subjects with the MTHFR TT genotype had a significantly higher methyl group acceptance capacity in their lymphocyte DNA compared with those with the wild-type MTHFR genotype, indicating global DNA hypomethylation in TT. 46 During folate restriction, mean percentage reduction in adoMet in TT was greater than in CC, suggesting that TT was more sensitive to folate restriction with respect to adoMet homeostasis in these lymphoblasts. However, despite the drastic reduction in adoMet, mild folate restriction did not alter the content of dMC in the DNA in any of the cell lines investigated. Under physiological conditions, chronic folate deficiency may lead to hypomethylation for prolonged periods. Therefore, we speculate that global DNA hypomethylation might occur after a prolonged period of low folate concentration. Further experiments that investigate the effect of chronic and severe folate depletion on genome-wide and gene-specific promoter methylation are underway.
In conclusion, our present study indicated that (1) the impacts of MTHFR 677T polymorphism are closely related to folate status. (2) TT is associated with relatively greater utilization of one-carbon units in purine synthesis when folate supply is optimal, but this advantage in purine synthesis is absent in folate restriction, as purine synthesis did not differ between TT and CC under mild folate restriction. (3) Mild folate restriction has greater impacts on methionine regeneration and adoMet syntheses in TT, and under this condition, the decreased MTHFR activity may direct one-carbon unit transfer toward purine synthesis at the expense of adoMet synthesis. We suggest that this nucleotide supply may be sufficient to decrease the chance of uracil misincorporation and contribute to better DNA repair machinery when folate is adequate. The advantage of de novo purine synthesis found in the MTHFR TT genotype may account for the protective effect of MTHFR against hematological malignancies. These transformed cells provide a model for studying the consequences of human genetic variation and their relationship to pathways involved in cancer pathogenesis or progression.
